Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Addiction Science & Clinical Practice
Published in: Addiction Science & Clinical Practice 1/2015

Open Access 01-12-2015 | Meeting abstract

Does drug treatment improve patient quality of life? A pilot study of the outcomes of the quality of life assessment in New York City outpatient and opioid treatment programs

Authors: Mindy D Nass, Anne E Siegler, Lara Maldjian, Luke Bergmann, Hillary V Kunins

Published in: Addiction Science & Clinical Practice | Special Issue 1/2015

Login to get access

Excerpt

The Affordable Care Act and the Medicaid redesign in New York City offer opportunities to explore alternative methods for measuring the effectiveness of behavioral health interventions. Quality of life (QOL) measures have been underutilized in substance use disorders treatment (SUDT). The objective of this study was to determine how a validated QOL instrument could be used in SUDT as a measure of health-related patient outcomes. …
Literature
1.
WHOQOL group development of the world health organization WHOQOL-BREF quality of life assessment.: 28. Psychol Medicine. 1998, 551-558.
2.
Bonomi AE, Patrick DL, Bushnell DM, Martin M.: Validation of the United States’ version of the world health organization quality of life (WHOQOL) instrument. J Clin Epidemiol. 2000, 53 (1): 1-12. 10.1016/S0895-4356(99)00123-7.CrossRefPubMed
Metadata
Title
Does drug treatment improve patient quality of life? A pilot study of the outcomes of the quality of life assessment in New York City outpatient and opioid treatment programs
Authors
Mindy D Nass
Anne E Siegler
Lara Maldjian
Luke Bergmann
Hillary V Kunins
Publication date
01-12-2015
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1940-0640-10-S1-A43

Other articles of this Special Issue 1/2015

Addiction Science & Clinical Practice 1/2015 Go to the issue

Meeting abstract

Perceived need for HIV testing among rural and urban African American cocaine users

Meeting abstract

Building sustainable SBIRT in an integrated hospital system in New York

Meeting abstract

Optimizing continuity-of-care opportunities to reduce health risks: shared qualitative perspectives from CJDATS 2 research

Meeting abstract

Client involvement in a web-based intervention targeting substance abuse treatment in the criminal justice system

Meeting abstract

Delivery and payment reform in Massachusetts: substance use disorder treatment organizations’ perspectives

Meeting abstract

Validation of computer self-administered screening and assessment tools to identify unhealthy substance use in medical patients